Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease

Author:

Wiest Maximilian Robert Justus1ORCID,Toro Mario Damiano123ORCID,Nowak Albina45,Bajka Anahita1,Fasler Katrin1,Al-Sheikh Mayss1ORCID,Hamann Timothy1,Zweifel Sandrine Anne1ORCID

Affiliation:

1. Department of Ophthalmology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland

2. Eye Clinic, Public Health Department, Federico II University, 80131 Naples, Italy

3. Chair and Department of Ophthalmology with Pediatric Service, Medical University of Lublin, 20079 Lublin, Poland

4. Department of Endocrinology and Clinical Nutrition, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland

5. Department of Internal Medicine, Psychiatry University Clinic Zurich, 8091 Zurich, Switzerland

Abstract

Background: Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measuring vessel density (VD), vessel length density (VLD), and the ratio of VD to VLD (VD/VLD) in superficial capillary plexuses (SCP) and deep capillary plexuses (DCP) using OCTA in patients with FD and to show whether they differ from healthy controls (HC); Patients and methods: Single-center, retrospective, consecutive cohort study of patients with genetically proven FD. Patients underwent an ophthalmological examination including OCTA. VD, VLD, foveal avascular zone (FAZ), and the VD/VLD were compared to an HC group using a linear mixed model; Results: A statistically significant difference in the VLD and VD/VLD of DCP was observed between the two groups (p < 0.001). Using ROC curves with AUC and Youden’s Index, a cut-off value for differentiating both groups using VD/VLD in DCP FD with high specificity and high sensitivity was established; Conclusions: FD and HC groups seem to be separable using the VD/VLD ratio in DCP. This new biomarker might differentiate changes in the retinal microvasculature that are not detectable by VD or VLD alone.

Funder

Novartis Pharma CH AG

Publisher

MDPI AG

Subject

Clinical Biochemistry

Reference55 articles.

1. Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill.

2. Computer assisted evaluation of retinal vessels tortuosity in Fabry disease;Sodi;Acta Ophthalmol.,2013

3. Biomarkers for Diagnosing and Staging of Fabry Disease;Kramer;Curr. Med. Chem.,2018

4. Computer Assisted Retinal Vessel Tortuosity Evaluation in Novel Mutation Fabry Disease: Towards New Prognostic Markers;Rodriguez;Retina,2017

5. Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up;Siegenthaler;Int. J. Cardiol.,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3